ANTH (OTC)
ANTHERA PHARMS INC NEW
$0.000100
+0.000000 (+0.00%)
Prev close: $0.000100
Company Information
- Exchange
- OTC Link
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- John Craig Thompson, MBA
- Asset Type
- otc
- Website
- —
Fundamentals
- Market Cap
- $0.00M
- Employees
- 21
- P/E (TTM)
- —
- P/B (TTM)
- —
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2018 (Q1)
|
$-0.57 | $-0.56 | -0.0090 | -1.60% |
|
Dec 2017 (Q4)
|
$-0.73 | $-0.68 | -0.0550 | -8.15% |
|
Sep 2017 (Q3)
|
$-0.58 | $-0.93 | +0.3513 | +37.72% |
|
Jun 2017 (Q2)
|
$-0.86 | $-1.11 | +0.2505 | +22.56% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $13.41M |
| Operating Expenses | $36.80M |
| Research and Development | $28.26M |
| Other Operating Expenses | $8.54M |
| Operating Income/Loss | -$36.80M |
| Income/Loss From Continuing Operations After Tax | -$23.39M |
| Income/Loss From Continuing Operations Before Tax | $5.54M |
| Net Income/Loss | -$23.39M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$23.39M |
| Net Income/Loss Available To Common Stockholders, Basic | -$24.93M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $1.54M |
| Preferred Stock Dividends And Other Adjustments | $1.54M |
| Assets | $8.81M |
| Current Assets | $8.74M |
| Noncurrent Assets | $72.00K |
| Fixed Assets | $72.00K |
| Liabilities | $3.35M |
| Current Liabilities | $2.65M |
| Accounts Payable | $1.85M |
| Other Current Liabilities | $801.00K |
| Noncurrent Liabilities | $704.00K |
| Equity | $5.46M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $5.46M |
| Liabilities And Equity | $8.81M |
| Net Cash Flow From Operating Activities | -$31.95M |
| Net Cash Flow From Operating Activities, Continuing | -$31.95M |
| Net Cash Flow From Financing Activities | $19.03M |
| Net Cash Flow From Financing Activities, Continuing | $19.03M |
| Net Cash Flow | -$12.57M |
| Net Cash Flow, Continuing | -$12.57M |
| Comprehensive Income/Loss | -$23.39M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$23.39M |
| Other Comprehensive Income/Loss | $0.00 |